pubs.acs.org/joc
PdCl2-Promoted Electrophilic Annulation of 2-Alkynylphenol Derivatives
with Disulfides or Diselenides in the Presence of Iodine
Hui-Ai Du, Xing-Guo Zhang,* Ri-Yuan Tang, and Jin-Heng Li*
College of Chemistry and Materials Science, Wenzhou University, Wenzhou 325035, China
jhli@hunnu.edu.cn; xgzhang99@yahoo.com.cn
Received July 27, 2009
An efficient synthesis of 3-chalcogen-benzo[b]furans via palladium-promoted annulation reactions
of 2-alkynylphenol derivatives with disulfides or diselenides and iodide has been developed. In the
presence of I2 and PdCl2, both 3-sulfenylbenzofurans and 3-selenenylbenzofurans were selectively
prepared from the cyclization of 2-alkynyanisoles with disulfides or diselenides in moderate to
excellent yields.
Introduction
as anticancer,2 antiproliferative,3 antiviral,4 antifungal,5 and
immunosuppressive.6 Therefore, the development of effi-
cient strategies for the construction of benzofuran scaffold
is a hot topic in organic synthsis.7 However, the synthesis of
Benzofurans, an important class of heterocyclic com-
pounds, are widely presented in a great number of biologi-
cally active compounds and natural products,1 which are
identified for their potential in major therapeutic areas such
(5) (a) Carter, G. A.; Chamberlain, K.; Wain, R. L. Ann. Appl. Biol. 1978,
88, 57. (b) Zacchino, S.; Rodriguez, G.; Pezzenati, G.; Orellana, G.; Enriz,
R.; Gonzalez, S. M. J. Nat. Prod. 1997, 60, 659.
(1) (a) Donnelly, D. M. X.; Meegan, M. J. In Comprehensive Heterocyclic
Chemistry; Katritzky, A. R., Rees, C. W., Eds.; Pergamon Press: Oxford, 1984;
Vol. 4, pp 657-712. (b) Cagniant, P.; Cagniant, C. Adv. Heterocycl. Chem. 1975,
18, 343. (c) Ward, R. S. Nat. Prod. Rep. 1993, 10, 1. (d) Ward, R. S. Nat. Prod.
Rep. 1995, 12, 183. (e) Friedrichsen, W. In Comprehensive Heterocyclic
Chemistry II; Bird, C. W., Katritzky, A. R., Rees, C. W., Scriven, E. F. V.,
Eds.; Pergamon: London, 1996; Vol. 2, Chapter 2.7, pp 368-378. (f) Ward, R. S.
Nat. Prod. Rep. 1997, 14, 43. (g) Muhammad, I.; Li, X.-C.; Jacob, M. R.;
Tekwani, B. L.; Dunbar, D. C.; Ferreira, D. J. Nat. Prod. 2003, 66, 804. (h)
Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W.,
Scriven, E. F. V., Eds.; Pergamon Press: Oxford, UK, 1996; Vol. 2, pp 259-321.
(2) (a) Navarro, E.; Alonso, S. J.; Trujillo, J.; Jorge, E.; Perez, C. J. Nat.
Prod. 2001, 64, 134. (b) Lambert, J. D.; Meyers, R. O.; Timmermann, B. N.;
Dorr, R. T. Cancer Lett. 2001, 171, 47. (c) Takasaki, M. T.; Komatsu, K.;
Tokuda, H.; Nishino, H. Cancer Lett. 2000, 158, 53. (d) Banskota, A.;
Tezuka, Y.; Midorikawa, K.; Matsushige, K.; Kadota, S. J. Nat. Prod. 2000,
63, 1277. (e) Lee, S. K.; Cui, B.; Mehta, R. R.; Kinghorn, A. D.; Pezzuto, J.
M. Chem.-Biol. Interact. 1998, 115, 215. (f) Thompson, L. U.; Rickard, S.
E.; Orcheson, L. J.; Seidl, M. M. Carcinogenesis 1996, 17, 1373. (g) Thomp-
son, L. U.; Seidl, M. M.; Rickard, S. E.; Orcheson, L. J.; Fong, H. H. Nutr.
Cancer 1996, 26, 159.
(6) (a) Gordaliza, M.; Castro, M.; del Corral, J. M.; Lopez-Vazquez, M.;
Feliciano, A. S.; Faircloth, G. T. Bioorg. Med. Chem. Lett. 1997, 7, 2781. (b)
Cho, J. Y.; Kim, A. R.; Yoo, E. S.; Baik, K. U.; Park, M. H. J. Pharm.
Pharmacol. 1999, 51, 1267.
(7) For selected recent examples, see: (a) Liang, Y.; Tang, S.; Zhang, X.-
D.; Mao, L.-Q.; Xie, Y.-X.; Li, J.-H. Org. Lett. 2006, 8, 3017. (b) Chen, C.-y.;
Dormer, P. G. J. Org. Chem. 2005, 70, 6964. (c) Okitsu, T.; Nakazawa, D.;
Taniguchi, R.; Wada, A. Org. Lett. 2008, 10, 4967. (d) Sakai, N.; Uchida, N.;
Konakahara, T. Tetrahedron Lett. 2008, 49, 3437. (e) Huang, X.-C.; Liu, Y.-
L.; Liang, Y.; Pi, S.-F.; Wang, F.; Li, J.-H. Org. Lett. 2008, 10, 1525. (f) De
Luca, L.; Giacomelli, G.; Nieddu, G. J. Org. Chem. 2007, 72, 3955. (g)
Furstner, A.; Heilmann, E. K.; Davies, P. W. Angew. Chem., Int. Ed. 2007,
46, 4760. (h) Nakamura, I.; Mizushima, Y.; Yamamoto, Y. J. Am. Chem.
Soc. 2005, 127, 15022. (i) Furstner, A.; Davies, P. W. J. Am. Chem. Soc. 2005,
127, 15024. (j) Hu, Y.; Nawoschik, K. J.; Liao, Y.; Ma, J.; Fathi, R.; Yang, Z.
J. Org. Chem. 2004, 69, 2235. (k) Bates, C. G.; Saejueng, P.; Murphy, J. M.;
Venkataraman, D. Org. Lett. 2002, 4, 4727. (l) Carril, M.; SanMartin, R.;
Tellitu, I.; Domınguez, E. Org. Lett. 2006, 8, 1467. (m) Colobert, F.;
Castanet, A.-S.; Abillard, O. Eur. J. Org. Chem. 2005, 3334. (n) Arcadi,
A.; Cacchi, S.; Fabrizi, G.; Marinelli, F.; Moro, L. Synlett 1999, 1432. (o)
Barluenga, J.; Trincado, M.; Rubio, E.; Gonzalez, J. M. Angew. Chem., Int.
Ed 2003, 42, 2406. (p) Arcadi, A.; Cacchi, S.; Giuseppe, S. D.; Fabrizi, G.;
Marinelli, F. Org. Lett. 2002, 4, 2409. (q) Yue, D.; Larock, R. C. Org. Lett.
2004, 6, 1037. (r) Huang, Q.; Hunter, J. A.; Larock, R. C. J. Org. Chem. 2002,
67, 3437. (s) Ajad, M.; Knight, D. W. Tetrahedron Lett. 2004, 45, 539.
(3) Ikeda, R.; Nagao, T.; Okabe, H.; Nakano, Y.; Matsunaga, H.;
Katano, M.; Mori, M. Chem. Pharm. Bull. 1998, 46, 871.
(4) (a) Craigo, J.; Callahan, M.; Huang, R. C. C.; DeLucia, A. L. Antiviral
Res. 2000, 47, 19. (b) Leung, C.; Charlton, J. L.; Cow, C. Can. J. Chem. 2000,
78, 553. (c) Charlton, J. L. J. Nat. Prod. 1998, 61, 1447.
7844 J. Org. Chem. 2009, 74, 7844–7848
Published on Web 09/25/2009
DOI: 10.1021/jo9016309
r
2009 American Chemical Society